Literature DB >> 16998463

Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: A study of 18 cases.

Mousa A Al-Abbadi1, Eyas M Hattab, Musleh S Tarawneh, Samir S Amr, Attilio Orazi, Thomas M Ulbright.   

Abstract

The most common type of primary testicular lymphoma is diffuse large B-cell type, which has the potential for aggressive clinical behavior. Diffuse large B-cell lymphoma can be further subclassified into two major prognostic categories: germinal center B-cell-like and nongerminal center B-cell-like. Such distinction is made possible using the immunohistochemical expression of CD10, Bcl-6 and MUM1. The aim of this study was to stratify primary testicular lymphoma of the diffuse large B-cell type according to this scheme. Immunohistochemical stains for CD10, Bcl-6 and MUM1 were performed on 18 cases of primary testicular lymphoma of diffuse large B-cell type. Subclassification was carried out as previously described where CD10 and/or Bcl-6 positivity and negativity for MUM1 were considered indicative of germinal center B-cell-like type and the opposite expression as nongerminal center B-cell-like type. The proliferative activity was determined using immunostaining with the Ki-67 antibody. Of 18 cases, 16 (89%) were found to belong to the nongerminal center B-cell-like type. Two cases (11%) were classified as germinal center B-cell-like type; one had a CD10-positive, Bcl-6-positive and MUM1-negative profile, and the other was CD10 negative, Bcl-6 positive and MUM1 negative. The former occurred in a 38-year-old patient who was human immunodeficiency virus positive. All the cases expressed high proliferative activity (> or =50% Ki-67 labeling). We conclude that most (89%) primary testicular lymphomas of the diffuse large B-cell type belong to the nongerminal center B-cell-like subgroup and have high proliferative activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998463     DOI: 10.1038/modpathol.3800691

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  16 in total

Review 1.  Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification.

Authors:  Elaine S Jaffe; Stefania Pittaluga
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

2.  Primary diffuse large B-cell lymphoma of the oral cavity: germinal center classification.

Authors:  Indraneel Bhattacharyya; Hardeep K Chehal; Donald M Cohen; Samer Z Al-Quran
Journal:  Head Neck Pathol       Date:  2010-06-09

3.  Unusually Aggressive Primary Testicular Diffuse Large B Cell Lymphoma with Post Therapy Extensive Metastasis.

Authors:  Shalini Goel; Ritesh Sachdev; Ishani Mohapatra; Smeeta Gajendra; Sunil Gupta
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 4.  The histological classification of diffuse large B-cell lymphomas.

Authors:  Yi Xie; Stefania Pittaluga; Elaine S Jaffe
Journal:  Semin Hematol       Date:  2015-01-17       Impact factor: 3.851

5.  Primary follicular lymphoma of the testis in children and adolescents.

Authors:  Mark A Lones; Martine Raphael; Keith McCarthy; Andrew Wotherspoon; Marie-Josee Terrier-Lacombe; Alan D Ramsay; Ken Maclennan; Mitchell S Cairo; Mary Gerrard; Jean Michon; Catherine Patte; Ross Pinkerton; Leonard Sender; Anne Auperin; Richard Sposto; Claire Weston; Nyla A Heerema; Warren G Sanger; Daniel von Allmen; Sherrie L Perkins
Journal:  J Pediatr Hematol Oncol       Date:  2012-01       Impact factor: 1.289

Review 6.  Primary testicular lymphoma: experience with 13 cases and literature review.

Authors:  Chu Wang; Hai Wang; Qinghai Wang; Bingbing Shi
Journal:  Int J Hematol       Date:  2013-01-25       Impact factor: 2.490

Review 7.  The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.

Authors:  Madhu P Menon; Stefania Pittaluga; Elaine S Jaffe
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360

8.  Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium.

Authors:  L Deng; Z Y Xu-Monette; S Loghavi; G C Manyam; Y Xia; C Visco; J Huh; L Zhang; Q Zhai; Y Wang; L Qiu; K Dybkær; A Chiu; A M Perry; S Zhang; A Tzankov; H Rao; J Abramson; A R Sohani; M Xu; E D Hsi; J Zhu; M Ponzoni; S Wang; Ling Li; M Zhang; A J M Ferreri; B M Parsons; Y Li; M A Piris; L J Medeiros; K H Young
Journal:  Leukemia       Date:  2013-08-26       Impact factor: 11.528

9.  Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era.

Authors:  Anita Kumar; Matthew A Lunning; Zhigang Zhang; Jocelyn C Migliacci; Craig H Moskowitz; Andrew D Zelenetz
Journal:  Br J Haematol       Date:  2015-10-12       Impact factor: 6.998

10.  Primary testicular lymphoma with rupture: An unusual presentation.

Authors:  K Vidyavathi; Kalyani Prabhakar; Kumar M L Harendra
Journal:  J Nat Sci Biol Med       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.